|
1
|
Adsay NV, Andea A, Basturk O, Kilinc N,
Nassar H and Cheng JD: Secondary tumors of the pancreas: An
analysis of a surgical and autopsy database and review of the
literature. Virchows Arch. 444:527–535. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zerbi A, Ortolano E, Balzano G, Borri A,
Beneduce AA and Di Carlo V: Pancreatic metastasis from renal cell
carcinoma: Which patients benefit from surgical resection? Ann Surg
Oncol. 15:1161–1168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roland CF and van Heerden JA:
Nonpancreatic primary tumors with metastasis to the pancreas. Surg
Gynecol Obstet. 168:345–347. 1989.PubMed/NCBI
|
|
4
|
Faure JP, Tuech JJ, Richer JP, Pessaux P,
Arnaud JP and Carretier M: Pancreatic metastasis of renal cell
carcinoma: Presentation, treatment and survival. J Urol. 165:20–22.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crippa S, Angelini C, Mussi C, Bonardi C,
Romano F, Sartori P, Uggeri F and Bovo G: Surgical treatment of
metastatic tumors to the pancreas: A single center experience and
review of the literature. World J Surg. 30:1536–1542. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adler H, Redmond CE, Heneghan HM, Swan N,
Maguire D, Traynor O, Hoti E, Geoghegan JG and Conlon KC:
Pancreatectomy for metastatic disease: A systematic review. Eur J
Surg Oncol. 40:379–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tsitouridis I, Diamantopoulou A,
Michaelides M, Arvanity M and Papaioannou S: Pancreatic metastases:
CT and MRI findings. Diagn Interv Radiol. 16:45–51. 2010.PubMed/NCBI
|
|
8
|
Mallery JS, Centeno BA, Hahn PF, Chang Y,
Warshaw AL and Brugge WR: Pancreatic tissue sampling guided by EUS,
CT/US, and surgery: A comparison of sensitivity and specificity.
Gastrointest Endosc. 56:218–224. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chu PG, Chung L, Weiss LM and Lau SK:
Determining the site of origin of mucinous adenocarcinoma: An
immunohistochemical study of 175 cases. Am J Surg Pathol.
35:1830–1836. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zerbi A and Pecorelli N: Pancreatic
metastases: An increasing clinical entity. World J Gastrointest
Surg. 2:255–259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reddy S and Wolfgang CL: The role of
surgery in the management of isolated metastases to the pancreas.
Lancet Oncol. 10:287–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Radulovic S and Bjelogrlic SK: Sunitinib,
sorafenib and mTOR inhibitors in renal cancer. J Buon. 12 Suppl
1:S151–S162. 2007.PubMed/NCBI
|
|
13
|
Medioni J, Choueiri TK, Zinzindohoue F,
Cho D, Fournier L and Oudard S: Response of renal cell carcinoma
pancreatic metastasis to sunitinib treatment: A retrospective
analysis. J Urol. 181:2470–2475. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jarufe N, McMaster P, Mayer AD, Mirza DF,
Buckels JA, Orug T, Tekin K and Bramhall SR: Surgical treatment of
metastases to the pancreas. Surgeon. 3:79–83. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Markinez I, Jiménez R, Ruiz I, Villarreal
E, Lizarazu A, Borda N, Arteaga X, Medrano MÁ, Guisasola E,
Beguiristain A and Enríquez-Navascués JM: Pancreatic metastases due
to renal carcinoma. Our cases and a literature review. Cir Esp.
91:90–95. 2013.(In Spanish).
|
|
16
|
Machado NO and Chopra P: Pancreatic
metastasis from renal carcinoma managed by Whipple resection. A
case report and literature review of metastatic pattern, surgical
management and outcome. JOP. 10:413–418. 2009.PubMed/NCBI
|
|
17
|
El Hajj II, LeBlanc JK, Sherman S,
Al-Haddad MA, Cote GA, McHenry L and DeWitt JM: Endoscopic
ultrasound-guided biopsy of pancreatic metastases: A large
single-center experience. Pancreas. 42:524–530. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smith AL, Odronic SI, Springer BS and
Reynolds JP: Solid tumor metastases to the pancreas diagnosed by
FNA: A single-institution experience and review of the literature.
Cancer Cytopathol. 123:347–355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thompson LD and Heffess CS: Renal cell
carcinoma to the pancreas in surgical pathology material. Cancer.
89:1076–1088. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hiotis SP, Klimstra DS, Conlon KC and
Brennan MF: Results after pancreatic resection for metastatic
lesions. Ann Surg Oncol. 9:675–679. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Klein KA, Stephens DH and Welch TJ: CT
characteristics of metastatic disease of the pancreas.
Radiographics. 18:369–378. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Le Borgne J, Partensky C, Glemain P, Dupas
B and de Kerviller B: Pancreaticoduodenectomy for metastatic
ampullary and pancreatic tumors. Hepatogastroenterology.
47:540–544. 2000.PubMed/NCBI
|
|
23
|
Nakamura E, Shimizu M, Itoh T and Manabe
T: Secondary tumors of the pancreas: Clinicopathological study of
103 autopsy cases of Japanese patients. Pathol Int. 51:686–690.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sweeney AD, Fisher WE, Wu MF, Hilsenbeck
SG and Brunicardi FC: Value of pancreatic resection for cancer
metastatic to the pancreas. J Surg Res. 160:268–276. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ahmed S, Johnson PT, Hruban R and Fishman
EK: Metastatic disease to the pancreas: Pathologic spectrum and CT
patterns. Abdom Imaging. 38:144–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song SW, Cheng JF, Liu N and Zhao TH:
Diagnosis and treatment of pancreatic metastases in 22 patients: A
retrospective study. World J Surg Oncol. 12:2992014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen L and Brainard JA: Pancreatic
metastasis from papillary thyroid carcinoma diagnosed by endoscopic
ultrasound-guided fine needle aspiration: A case report. Acta
Cytol. 54:640–644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ardengh JC, Lopes CV, Kemp R, Venco F, de
Lima-Filho ER and dos Santos JS: Accuracy of endoscopic
ultrasound-guided fine-needle aspiration in the suspicion of
pancreatic metastases. Bmc Gastroenterol. 13:632013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saiz M, Alvarez-Cubero MJ,
Martinez-González LJ, Alvarez JC, Lorente M and Lorente JA: The
identification of individuals through genetic testing and DNA
profiling banks. Rev Derecho Genoma Hum. 157–168. 2014.PubMed/NCBI
|
|
30
|
Krasinskas AM, Chiosea SI, Pal T and Dacic
S: KRAS mutational analysis and immunohistochemical studies can
help distinguish pancreatic metastases from primary lung
adenocarcinomas. Mod Pathol. 27:262–270. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu J, Chu PG, Jiang Z and Lau SK: Napsin A
expression in primary mucin-producing adenocarcinomas of the lung:
An immunohistochemical study. Am J Clin Pathol. 139:160–166. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stoll LM, Johnson MW, Gabrielson E, Askin
F, Clark DP and Li QK: The utility of napsin-A in the
identification of primary and metastatic lung adenocarcinoma among
cytologically poorly differentiated carcinomas. Cancer Cytopathol.
118:441–449. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hruban RH, van Mansfeld AD, Offerhaus GJ,
van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK,
Cameron JL and Bos JL: K-ras oncogene activation in adenocarcinoma
of the human pancreas. A study of 82 carcinomas using a combination
of mutant-enriched polymerase chain reaction analysis and
allele-specific oligonucleotide hybridization. Am J Pathol.
143:545–554. 1993.PubMed/NCBI
|
|
34
|
Dacic S, Shuai Y, Yousem S, Ohori P and
Nikiforova M: Clinicopathological predictors of EGFR/KRAS
mutational status in primary lung adenocarcinomas. Mod Pathol.
23:159–168. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Oliveira-Cunha M, Hadfield KD, Siriwardena
AK and Newman W: EGFR and KRAS mutational analysis and their
correlation to survival in pancreatic and periampullary cancer.
Pancreas. 41:428–434. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Patard JJ, Rioux-Leclercq N, Masson D,
Zerrouki S, Jouan F, Collet N, Dubourg C, Lobel B, Denis M and
Fergelot P: Absence of VHL gene alteration and high VEGF expression
are associated with tumour aggressiveness and poor survival of
renal-cell carcinoma. Br J Cancer. 101:1417–1424. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Reddy S, Edil BH, Cameron JL, Pawlik TM,
Herman JM, Gilson MM, Campbell KA, Schulick RD, Ahuja N and
Wolfgang CL: Pancreatic resection of isolated metastases from
nonpancreatic primary cancers. Ann Surg Oncol. 15:3199–3206. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Strobel O, Hackert T, Hartwig W, Bergmann
F, Hinz U, Wente MN, Fritz S, Schneider L, Büchler MW and Werner J:
Survival data justifies resection for pancreatic metastases. Ann
Surg Oncol. 16:3340–3349. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Niess H, Conrad C, Kleespies A, Haas F,
Bao Q, Jauch KW, Graeb C and Bruns CJ: Surgery for metastasis to
the pancreas: Is it safe and effective? J Surg Oncol. 107:859–864.
2013. View Article : Google Scholar : PubMed/NCBI
|
